Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0000950168-02-000282
Filing Date
2002-02-22
Accepted
2002-02-22 00:00:00
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 ds3a.txt S-3/A 205635
3 UNDERWRITING AGREEMENT dex11.txt EX-1.1 108160
4 CONSENT OF INDEPENDENT AUDITORS dex231.txt EX-23.1 1235
  Complete submission text file 0000950168-02-000282.txt   316803
Mailing Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615
Business Address 8540 COLONNADE CENTER DR SUITE 501 RALEIGH NC 27615 9198621000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

EIN.: 943267443 | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-82558 | Film No.: 02556548
SIC: 2834 Pharmaceutical Preparations